1610056-01-3
|
|
|
- CAS号:
- 1610056-01-3
- 英文名:
- Peptide T TFA
- 英文别名:
- Peptide T TFA;((2S)-2-((2S,3R)-2-((2S,3R)-2-((S)-2-((S)-2-aminopropanamido)-3-hydroxypropanamido)-3-hydroxybutanamido)-3-hydroxybutanamido)-3-hydroxybutanoyl)-L-asparaginyl-L-tyrosyl-L-threonine compound with 2,2,2-trifluoroacetic acid (1:1)
- 中文名:
- 1610056-01-3
- 中文别名:
- CBNumber:
- CB24713793
- 分子式:
- C37H56F3N9O18
- 分子量:
- 971.9
- MOL File:
- 1610056-01-3.mol
|
|
|
1610056-01-3化学性质
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
Soluble in DMSO
-
|
1610056-01-3性质、用途与生产工艺
Peptide T (TFA) 是源自HIV-1 gp120的V2区的八肽。 Peptide T是 CD4 受体的配体，可阻止 HIV 与CD4受体结合。
Peptide T acts to block viral entry as it inhibits in the MAGI cell assay and blocks infection in the luciferase reporter assay using HIV virions pseudotyped with ADA envelope. Peptide T selectively inhibits HIV replication using chemokine receptor CCR5 compared to CXC4. Peptide T at 10
-8
M induces IL-10 production by the human Th2 cell line and PBMC. Also peptide T at 10
-9
M concentration significantly inhibits IFN-g production by PBMC.
Peptide T is administered subcutaneously at different doses and phases of the experimental autoimmune encephalomyelitis (EAE) disease, but Peptide T neither prevents nor ameliorates EAE.
1610056-01-3
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2023/03/20 | HY-P0272A | 1610056-01-3
Peptide T TFA | 1610056-01-3 | 1mg | 1000元 |
| 2023/03/20 | HY-P0272A | 1610056-01-3
Peptide T TFA | 1610056-01-3 | 5mg | 2900元 |
1610056-01-3, 1610056-01-3 相关搜索:
- 1610056-01-3
- ((2S)-2-((2S,3R)-2-((2S,3R)-2-((S)-2-((S)-2-aminopropanamido)-3-hydroxypropanamido)-3-hydroxybutanamido)-3-hydroxybutanamido)-3-hydroxybutanoyl)-L-asparaginyl-L-tyrosyl-L-threonine compound with 2,2,2-trifluoroacetic acid (1:1)
- Peptide T TFA